Rigel Pharmaceuticals
RIGL
RIGL
120 hedge funds and large institutions have $187M invested in Rigel Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 120 → 120 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
120
Holding in Top 10
1
Calls
$524K
Puts
$242K
Top Buyers
| 1 | +$3.54M | |
| 2 | +$1.78M | |
| 3 | +$1.56M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$972K |
| 5 |
JGC
J. Goldman & Co
New York
|
+$703K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$1.41M | |
| 3 | -$632K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$540K |
| 5 |
SAM
Senzar Asset Management
New York
|
-$386K |